SCHEMBL15575646

SCHEMBL15575646

N[C@H]1CC[C@H](OCc2ccccc2)C1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.49
CTSL P07711 1/20 0.46
CTSB P07858 1/20 0.46
CTSK P43235 1/20 0.46
OPRM1 P35372 2/20 0.45
OPRL1 P41146 2/20 0.45
TMEM97 Q5BJF2 1/20 0.43
CARM1 Q86X55 1/20 0.43
PRMT6 Q96LA8 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
PRMT8 Q9NR22 1/20 0.43
HRH3 Q9Y5N1 1/20 0.43
AGTR2 P50052 2/20 0.42
EPHX2 P34913 1/20 0.42
TRPM8 Q7Z2W7 3/20 0.41
KDM1A O60341 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
IDO1 P14902 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15575648 1.00 DPP4 (0.49) DPP4CTSLCTSBCTSKOPRM1
SCHEMBL15575649 1.00 DPP4 (0.49) DPP4CTSLCTSBCTSKOPRM1
SCHEMBL18579857 0.90 NAAA (0.52) DPP4CARM1PRMT6IDO1
SCHEMBL2124907 0.90 TRPM8 (0.48) DPP4CTSLCTSBCTSKOPRM1
SCHEMBL1241681 0.89 DPP4 (0.55) DPP4CTSLCTSBCTSKOPRM1
SCHEMBL1241683 0.89 DPP4 (0.55) DPP4CTSLCTSBCTSKOPRM1
Hydrochloric Acid SCHEMBL25392133 0.88 TRPM8 (0.47) DPP4CTSLCTSBCTSKOPRM1
Hydrochloric Acid SCHEMBL25392132 0.88 TRPM8 (0.47) DPP4CTSLCTSBCTSKOPRM1
Hydrochloric Acid SCHEMBL3211141 0.87 DPP4 (0.54) DPP4CTSLCTSBCTSKOPRM1
Hydrochloric Acid SCHEMBL3211138 0.87 DPP4 (0.54) DPP4CTSLCTSBCTSKOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9505749-B2 Quinazolinone compounds and derivatives thereof AMGEN INC. (US) 2016-11-29 US disclosed
US-20150225396-A1 Quinazolinone Compounds and Derivatives Thereof AMGEN INC. 2015-08-13 US disclosed
EP-2890696-A1 QUINAZOLINONE COMPOUNDS AND DERIVATIVES THEREOF AMGEN, INC. (US) 2015-07-08 EP disclosed
WO-2014036022-A1 QUINAZOLINONE COMPOUNDS AND DERIVATIVES THEREOF AMGEN INC. (US) 2014-03-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150225396-A1 Quinazolinone Compounds and Derivatives Thereof TNKS, TPI1, TNKS1BP1 DPP4 738/4885CTSL 1743/4885CTSB 1475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.